Home › GlaxoSmithKline plc's (GSK) Neutral Rating Reaffirmed at BNP Paribas
 

Keywords :   


GlaxoSmithKline plc's (GSK) Neutral Rating Reaffirmed at BNP Paribas

2016-01-09 20:38:11| Biotech - Topix.net

's stock had its "neutral" rating restated by analysts at BNP Paribas in a report issued on Friday, MarketBeat Ratings reports. They presently have a GBX 1,400 target price on the stock.

Tags: rating neutral bnp reaffirmed

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Eastern North Pacific Tropical Weather Outlook
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 12
28.09Tropical Storm Joyce Graphics
28.09Hurricane Isaac Wind Speed Probabilities Number 12
28.09Hurricane Isaac Forecast Advisory Number 12
28.09Hurricane Isaac Public Advisory Number 12
28.09Summary for Hurricane Isaac (AT5/AL102024)
More »